Unexpected placebo response in premenstrual dysphoric disorder: implication of endogenous opioids.
Van Ree
Jan M
JM
Schagen Van Leeuwen
Jules H
JH
Koppeschaar
Hans P
HP
Te Velde
Egbert R
ER
D004311:Double-Blind Method; D005260:Female; D006801:Humans; D019964:Mood Disorders / Q000209:etiology*; D009271:Naltrexone / Q000031:analogs & derivatives / Q000627:therapeutic use; D018847:Opioid Peptides / Q000502:physiology*; D010865:Pilot Projects; D015990:Placebo Effect; D011293:Premenstrual Syndrome / Q000209:etiology*; D011795:Surveys and Questionnaires; D001615:beta-Endorphin / Q000097:blood
D018847:Opioid Peptides; D009271:Naltrexone; D001615:beta-Endorphin; C038981:nalmefene